SMART Health Cards: Vaccination & Testing Implementation Guide
1.0.0 - STU1 International flag

SMART Health Cards: Vaccination & Testing Implementation Guide, published by HL7 International / Public Health. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-shc-vaccination-ig/ and changes regularly. See the Directory of published versions

ValueSet: Immunization / All / CVX

Official URL: http://hl7.org/fhir/uv/shc-vaccination/ValueSet/immunization-all-cvx Version: 1.0.0
Standards status: Trial-use Maturity Level: 4 Computable Name: ImmunizationAllCvxValueSet

Contains all CVX codes from https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx as of 2025-09-03. This list of codes will not update automatically, so please refer to this URL for the most up-to-date codes.the most up-to-date codes.

References

Logical Definition (CLD)

  • Include these codes as defined in http://hl7.org/fhir/sid/cvx
    CodeDisplay
    54adenovirus, type 4
    55adenovirus, type 7
    82adenovirus, unspecified formulation
    24Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis
    19BCG
    27botulinum antitoxin
    26cholera, unspecified formulation
    29CMVIG
    56dengue fever tetravalent
    12diphtheria antitoxin
    28DT (pediatric)
    20DTaP
    106DTaP, 5 pertussis antigens
    107DTaP, unspecified formulation
    110DTaP-Hep B-IPV
    50DTaP-Hib
    120DTaP-Hib-IPV
    130DTaP-IPV
    22DTP-Hib
    102DTP-Hib-Hep B
    57hantavirus
    52Hep A, adult
    83Hep A, ped/adol, 2 dose
    84Hep A, ped/adol, 3 dose
    31Hep A, pediatric, unspecified formulation
    85Hep A, unspecified formulation
    104Hep A-Hep B
    30HBIG
    42Hep B, adolescent/high risk infant
    43Hep B, adult
    44Hep B, high-dosage, dialysis or IC
    45Hep B, unspecified formulation
    58Hep C
    59Hep E
    60herpes simplex 2
    46Hib (PRP-D)
    47Hib (HbOC)
    48Hib (PRP-T)
    49Hib (PRP-OMP)
    17Hib, unspecified formulation
    51Hib-Hep B
    61HIV
    118HPV, bivalent
    62HPV, quadrivalent
    86IG
    87IGIV
    14IG, unspecified formulation
    111Influenza, live, trivalent, intranasal, PF
    15influenza, split (incl. purified surface antigen)
    16influenza, whole
    88influenza, unspecified formulation
    123influenza, H5N1-1203
    10IPV
    89polio, unspecified formulation
    39Japanese encephalitis SC
    63Junin virus
    64leishmaniasis
    65leprosy
    66Lyme disease
    94MMRV
    67malaria
    68melanoma
    32meningococcal MPSV4
    103meningococcal C conjugate
    114meningococcal MCV4P
    108meningococcal ACWY, unspecified formulation
    69parainfluenza-3
    11pertussis
    23plague
    33pneumococcal polysaccharide PPV23
    100pneumococcal conjugate PCV 7
    109pneumococcal, unspecified formulation
    70Q fever
    18rabies, intramuscular injection
    40rabies, intradermal injection
    90rabies, unspecified formulation
    72rheumatic fever
    73Rift Valley fever
    34RIG
    119rotavirus, monovalent
    122rotavirus, unspecified formulation
    116rotavirus, pentavalent
    74rotavirus, tetravalent
    71RSV-IGIV
    93RSV-MAb
    38rubella/mumps
    76Staphylococcus bacterio lysate
    113Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
    115Tdap
    35tetanus toxoid, adsorbed
    112tetanus toxoid, unspecified formulation
    77Tick-borne encephalitis vaccine (non-US)
    13TIG
    95TST-OT tine test
    96TST-PPD intradermal
    97TST-PPD tine test
    98TST, unspecified formulation
    78tularemia vaccine
    91typhoid, unspecified formulation
    25typhoid, oral
    41typhoid, parenteral
    53typhoid, parenteral, AKD (U.S. military)
    101typhoid, ViCPs
    75Vaccinia (smallpox, mpox), live
    105vaccinia (smallpox) diluted
    79vaccinia immune globulin
    21varicella
    81VEE, inactivated
    80VEE, live
    92VEE, unspecified formulation
    36VZIG
    117VZIG (IND)
    37yellow fever live
    121zoster live
    998no vaccine administered
    999unknown
    99RESERVED - do not use
    133Pneumococcal conjugate PCV 13
    134Japanese Encephalitis IM
    137HPV, unspecified formulation
    136Meningococcal MCV4O
    135Influenza, high-dose, trivalent, PF
    131typhus, historical
    132DTaP-IPV-HIB-HEP B, historical
    128Novel Influenza-H1N1-09, all formulations
    125Novel Influenza-H1N1-09, nasal
    126Novel influenza-H1N1-09, preservative-free
    127Novel influenza-H1N1-09
    138Td (adult)
    139Td(adult) unspecified formulation
    140Influenza, split virus, trivalent, PF
    129Japanese Encephalitis, unspecified formulation
    141Influenza, split virus, trivalent, preservative
    142tetanus toxoid, not adsorbed
    143Adenovirus types 4 and 7
    144influenza, seasonal, intradermal, preservative free
    145RSV-MAb (new)
    146DTaP,IPV,Hib,HepB
    147meningococcal MCV4, unspecified formulation
    148Meningococcal C/Y-HIB PRP
    149Influenza, live, quadrivalent, intranasal
    150Influenza, split virus, quadrivalent, PF
    151influenza nasal, unspecified formulation
    152Pneumococcal Conjugate, unspecified formulation
    153Influenza, MDCK, trivalent, PF
    154Hep A, IG
    155Influenza, recombinant, trivalent, PF
    156Rho(D)-IG
    157Rho(D) -IG IM
    158Influenza, split virus, quadrivalent, preservative
    159Rho(D) - Unspecified formulation
    160Influenza A monovalent (H5N1), ADJUVANTED-2013
    801AS03 Adjuvant
    161Influenza, injectable,quadrivalent, preservative free, pediatric
    162meningococcal B, recombinant
    163meningococcal B, OMV
    164meningococcal B, unspecified
    165HPV9
    166influenza, intradermal, quadrivalent, preservative free
    167meningococcal, unknown serogroups
    168Influenza, adjuvanted, trivalent, PF
    169Hep A, live attenuated
    170DTAP/IPV/HIB - non-US
    171Influenza, MDCK, quadrivalent, PF
    172cholera, WC-rBS
    173cholera, BivWC
    174cholera, live attenuated
    175Rabies - IM Diploid cell culture
    176Rabies - IM fibroblast culture
    177PCV10
    178OPV bivalent
    179OPV ,monovalent, unspecified
    180tetanus immune globulin
    181anthrax immune globulin
    182OPV, Unspecified
    183Yellow fever vaccine live - alt
    184Yellow fever, unspecified
    185Influenza, recombinant, quadrivalent, PF
    186Influenza, MDCK, quadrivalent, preservative
    187zoster recombinant
    188zoster, unspecified formulation
    189HepB-CpG
    190Typhoid conjugate vaccine (TCV)
    191meningococcal A polysaccharide (non-US)
    192meningococcal AC polysaccharide (non-US)
    193Hep A-Hep B, pediatric/adolescent
    194Influenza, Southern Hemisphere
    195DT, IPV adsorbed
    196Td, adsorbed, preservative free, adult use, Lf unspecified
    197Influenza, high-dose, quadrivalent, PF
    200influenza, Southern Hemisphere, pediatric, preservative free
    201Influenza, Southern Hemisphere, quadrivalent, PF
    202influenza, Southern Hemisphere, quadrivalent, with preservative
    198DTP-hepB-Hib Pentavalent Non-US
    203meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)
    205Influenza, adjuvanted, quadrivalent, PF
    206Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection
    207COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
    208COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
    213SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
    210COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL
    212COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL
    204Ebola Zaire vaccine, live, recombinant, 1mL dose
    214Ebola, unspecified
    211COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
    500COVID-19 Non-US Vaccine, Product Unknown
    501COVID-19 IV Non-US Vaccine (QAZCOVID-IN)
    502COVID-19 IV Non-US Vaccine (COVAXIN)
    503COVID-19 LAV Non-US Vaccine (COVIVAC)
    504COVID-19 VVnr Non-US Vaccine (Sputnik Light)
    505COVID-19 VVnr Non-US Vaccine (Sputnik V)
    506COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology
    507COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)
    508COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)
    509COVID-19 PS Non-US Vaccine (EpiVacCorona)
    510COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)
    511COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)
    215Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF
    216Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF
    219COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose
    217COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose
    218COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose
    220HepB recombinant, 3-antigen, Al(OH)3
    221COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose
    222Tick-borne encephalitis, unspecified
    223Tick-borne encephalitis, inactivated, PF, 0.25mL
    224Tick-borne encephalitis, inactivated, PF, 0.5mL
    225COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL
    226COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL
    512SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)
    513SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)
    514SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)
    515SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)
    516COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
    517SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)
    227COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose
    228COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose
    229COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose
    301COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose
    300COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose
    230COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL
    518COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
    519COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna
    520COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech
    521COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK
    231influenza, Southern Hemisphere, high-dose, quadrivalent
    303RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF
    304Respiratory syncytial virus (RSV), unspecified
    305RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF
    306RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months
    307RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months
    313COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL
    308COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL
    309COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL
    310COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL
    312COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL
    311COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL
    315Respiratory syncytial virus (RSV) MAB, unspecified
    314Respiratory syncytial virus (RSV) vaccine, unspecified
    316Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF
    317Chikungunya live attenuated vaccine, 0.5 mL, PF
    318Anthrax, post-exposure prophylaxis
    319Anthrax vaccine, unspecified
    320Influenza, MDCK, trivalent, preservative
    321Influenza-avian, H5N8, monovalent, PF
    322Influenza-avian, H5N8, monovalent, preservative
    324Poliovirus, inactivated, fractional-dose (fIPV)
    323Influenza-avian, H5, unspecified formulation
    326RSV, mRNA, injectable, PF
    327Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF
    328Meningococcal oligosaccharide (MenACWY), (MenB), PF
    329Chikungunya, VLP, recombinant, 0.8 mL, PF
    330Dengue fever, unspecified
    331Influenza, Southern Hemisphere, trivalent, PF
    325Vaccinia (smallpox, mpox), unspecified
    332RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF
    333Influenza, live, trivalent, intranasal, self/caregiver admin, PF
    302COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose

 

Expansion

Expansion from tx.fhir.org based on codesystem Vaccine Administered Code Set (CVX) version20250715

This value set contains 278 concepts

CodeSystemDisplay
  54http://hl7.org/fhir/sid/cvxadenovirus, type 4
  55http://hl7.org/fhir/sid/cvxadenovirus, type 7
  82http://hl7.org/fhir/sid/cvxadenovirus, unspecified formulation
  24http://hl7.org/fhir/sid/cvxAnthrax, pre-exposure prophylaxis, post-exposure prophylaxis
  19http://hl7.org/fhir/sid/cvxBCG
  27http://hl7.org/fhir/sid/cvxbotulinum antitoxin
  26http://hl7.org/fhir/sid/cvxcholera, unspecified formulation
  29http://hl7.org/fhir/sid/cvxCMVIG
  56http://hl7.org/fhir/sid/cvxdengue fever tetravalent
  12http://hl7.org/fhir/sid/cvxdiphtheria antitoxin
  28http://hl7.org/fhir/sid/cvxDT (pediatric)
  20http://hl7.org/fhir/sid/cvxDTaP
  106http://hl7.org/fhir/sid/cvxDTaP, 5 pertussis antigens
  107http://hl7.org/fhir/sid/cvxDTaP, unspecified formulation
  110http://hl7.org/fhir/sid/cvxDTaP-Hep B-IPV
  50http://hl7.org/fhir/sid/cvxDTaP-Hib
  120http://hl7.org/fhir/sid/cvxDTaP-Hib-IPV
  130http://hl7.org/fhir/sid/cvxDTaP-IPV
  22http://hl7.org/fhir/sid/cvxDTP-Hib
  102http://hl7.org/fhir/sid/cvxDTP-Hib-Hep B
  57http://hl7.org/fhir/sid/cvxhantavirus
  52http://hl7.org/fhir/sid/cvxHep A, adult
  83http://hl7.org/fhir/sid/cvxHep A, ped/adol, 2 dose
  84http://hl7.org/fhir/sid/cvxHep A, ped/adol, 3 dose
  31http://hl7.org/fhir/sid/cvxHep A, pediatric, unspecified formulation
  85http://hl7.org/fhir/sid/cvxHep A, unspecified formulation
  104http://hl7.org/fhir/sid/cvxHep A-Hep B
  30http://hl7.org/fhir/sid/cvxHBIG
  42http://hl7.org/fhir/sid/cvxHep B, adolescent/high risk infant
  43http://hl7.org/fhir/sid/cvxHep B, adult
  44http://hl7.org/fhir/sid/cvxHep B, high-dosage, dialysis or IC
  45http://hl7.org/fhir/sid/cvxHep B, unspecified formulation
  58http://hl7.org/fhir/sid/cvxHep C
  59http://hl7.org/fhir/sid/cvxHep E
  60http://hl7.org/fhir/sid/cvxherpes simplex 2
  46http://hl7.org/fhir/sid/cvxHib (PRP-D)
  47http://hl7.org/fhir/sid/cvxHib (HbOC)
  48http://hl7.org/fhir/sid/cvxHib (PRP-T)
  49http://hl7.org/fhir/sid/cvxHib (PRP-OMP)
  17http://hl7.org/fhir/sid/cvxHib, unspecified formulation
  51http://hl7.org/fhir/sid/cvxHib-Hep B
  61http://hl7.org/fhir/sid/cvxHIV
  118http://hl7.org/fhir/sid/cvxHPV, bivalent
  62http://hl7.org/fhir/sid/cvxHPV, quadrivalent
  86http://hl7.org/fhir/sid/cvxIG
  87http://hl7.org/fhir/sid/cvxIGIV
  14http://hl7.org/fhir/sid/cvxIG, unspecified formulation
  111http://hl7.org/fhir/sid/cvxInfluenza, live, trivalent, intranasal, PF
  15http://hl7.org/fhir/sid/cvxinfluenza, split (incl. purified surface antigen)
  16http://hl7.org/fhir/sid/cvxinfluenza, whole
  88http://hl7.org/fhir/sid/cvxinfluenza, unspecified formulation
  123http://hl7.org/fhir/sid/cvxinfluenza, H5N1-1203
  10http://hl7.org/fhir/sid/cvxIPV
  89http://hl7.org/fhir/sid/cvxpolio, unspecified formulation
  39http://hl7.org/fhir/sid/cvxJapanese encephalitis SC
  63http://hl7.org/fhir/sid/cvxJunin virus
  64http://hl7.org/fhir/sid/cvxleishmaniasis
  65http://hl7.org/fhir/sid/cvxleprosy
  66http://hl7.org/fhir/sid/cvxLyme disease
  94http://hl7.org/fhir/sid/cvxMMRV
  67http://hl7.org/fhir/sid/cvxmalaria
  68http://hl7.org/fhir/sid/cvxmelanoma
  32http://hl7.org/fhir/sid/cvxmeningococcal MPSV4
  103http://hl7.org/fhir/sid/cvxmeningococcal C conjugate
  114http://hl7.org/fhir/sid/cvxmeningococcal MCV4P
  108http://hl7.org/fhir/sid/cvxmeningococcal ACWY, unspecified formulation
  69http://hl7.org/fhir/sid/cvxparainfluenza-3
  11http://hl7.org/fhir/sid/cvxpertussis
  23http://hl7.org/fhir/sid/cvxplague
  33http://hl7.org/fhir/sid/cvxpneumococcal polysaccharide PPV23
  100http://hl7.org/fhir/sid/cvxpneumococcal conjugate PCV 7
  109http://hl7.org/fhir/sid/cvxpneumococcal, unspecified formulation
  70http://hl7.org/fhir/sid/cvxQ fever
  18http://hl7.org/fhir/sid/cvxrabies, intramuscular injection
  40http://hl7.org/fhir/sid/cvxrabies, intradermal injection
  90http://hl7.org/fhir/sid/cvxrabies, unspecified formulation
  72http://hl7.org/fhir/sid/cvxrheumatic fever
  73http://hl7.org/fhir/sid/cvxRift Valley fever
  34http://hl7.org/fhir/sid/cvxRIG
  119http://hl7.org/fhir/sid/cvxrotavirus, monovalent
  122http://hl7.org/fhir/sid/cvxrotavirus, unspecified formulation
  116http://hl7.org/fhir/sid/cvxrotavirus, pentavalent
  74http://hl7.org/fhir/sid/cvxrotavirus, tetravalent
  71http://hl7.org/fhir/sid/cvxRSV-IGIV
  93http://hl7.org/fhir/sid/cvxRSV-MAb
  38http://hl7.org/fhir/sid/cvxrubella/mumps
  76http://hl7.org/fhir/sid/cvxStaphylococcus bacterio lysate
  113http://hl7.org/fhir/sid/cvxTd (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
  115http://hl7.org/fhir/sid/cvxTdap
  35http://hl7.org/fhir/sid/cvxtetanus toxoid, adsorbed
  112http://hl7.org/fhir/sid/cvxtetanus toxoid, unspecified formulation
  77http://hl7.org/fhir/sid/cvxTick-borne encephalitis vaccine (non-US)
  13http://hl7.org/fhir/sid/cvxTIG
  95http://hl7.org/fhir/sid/cvxTST-OT tine test
  96http://hl7.org/fhir/sid/cvxTST-PPD intradermal
  97http://hl7.org/fhir/sid/cvxTST-PPD tine test
  98http://hl7.org/fhir/sid/cvxTST, unspecified formulation
  78http://hl7.org/fhir/sid/cvxtularemia vaccine
  91http://hl7.org/fhir/sid/cvxtyphoid, unspecified formulation
  25http://hl7.org/fhir/sid/cvxtyphoid, oral
  41http://hl7.org/fhir/sid/cvxtyphoid, parenteral
  53http://hl7.org/fhir/sid/cvxtyphoid, parenteral, AKD (U.S. military)
  101http://hl7.org/fhir/sid/cvxtyphoid, ViCPs
  75http://hl7.org/fhir/sid/cvxVaccinia (smallpox, mpox), live
  105http://hl7.org/fhir/sid/cvxvaccinia (smallpox) diluted
  79http://hl7.org/fhir/sid/cvxvaccinia immune globulin
  21http://hl7.org/fhir/sid/cvxvaricella
  81http://hl7.org/fhir/sid/cvxVEE, inactivated
  80http://hl7.org/fhir/sid/cvxVEE, live
  92http://hl7.org/fhir/sid/cvxVEE, unspecified formulation
  36http://hl7.org/fhir/sid/cvxVZIG
  117http://hl7.org/fhir/sid/cvxVZIG (IND)
  37http://hl7.org/fhir/sid/cvxyellow fever live
  121http://hl7.org/fhir/sid/cvxzoster live
  998http://hl7.org/fhir/sid/cvxno vaccine administered
  999http://hl7.org/fhir/sid/cvxunknown
  99http://hl7.org/fhir/sid/cvxRESERVED - do not use
  133http://hl7.org/fhir/sid/cvxPneumococcal conjugate PCV 13
  134http://hl7.org/fhir/sid/cvxJapanese Encephalitis IM
  137http://hl7.org/fhir/sid/cvxHPV, unspecified formulation
  136http://hl7.org/fhir/sid/cvxMeningococcal MCV4O
  135http://hl7.org/fhir/sid/cvxInfluenza, high-dose, trivalent, PF
  131http://hl7.org/fhir/sid/cvxtyphus, historical
  132http://hl7.org/fhir/sid/cvxDTaP-IPV-HIB-HEP B, historical
  128http://hl7.org/fhir/sid/cvxNovel Influenza-H1N1-09, all formulations
  125http://hl7.org/fhir/sid/cvxNovel Influenza-H1N1-09, nasal
  126http://hl7.org/fhir/sid/cvxNovel influenza-H1N1-09, preservative-free
  127http://hl7.org/fhir/sid/cvxNovel influenza-H1N1-09
  138http://hl7.org/fhir/sid/cvxTd (adult)
  139http://hl7.org/fhir/sid/cvxTd(adult) unspecified formulation
  140http://hl7.org/fhir/sid/cvxInfluenza, split virus, trivalent, PF
  129http://hl7.org/fhir/sid/cvxJapanese Encephalitis, unspecified formulation
  141http://hl7.org/fhir/sid/cvxInfluenza, split virus, trivalent, preservative
  142http://hl7.org/fhir/sid/cvxtetanus toxoid, not adsorbed
  143http://hl7.org/fhir/sid/cvxAdenovirus types 4 and 7
  144http://hl7.org/fhir/sid/cvxinfluenza, seasonal, intradermal, preservative free
  145http://hl7.org/fhir/sid/cvxRSV-MAb (new)
  146http://hl7.org/fhir/sid/cvxDTaP,IPV,Hib,HepB
  147http://hl7.org/fhir/sid/cvxmeningococcal MCV4, unspecified formulation
  148http://hl7.org/fhir/sid/cvxMeningococcal C/Y-HIB PRP
  149http://hl7.org/fhir/sid/cvxInfluenza, live, quadrivalent, intranasal
  150http://hl7.org/fhir/sid/cvxInfluenza, split virus, quadrivalent, PF
  151http://hl7.org/fhir/sid/cvxinfluenza nasal, unspecified formulation
  152http://hl7.org/fhir/sid/cvxPneumococcal Conjugate, unspecified formulation
  153http://hl7.org/fhir/sid/cvxInfluenza, MDCK, trivalent, PF
  154http://hl7.org/fhir/sid/cvxHep A, IG
  155http://hl7.org/fhir/sid/cvxInfluenza, recombinant, trivalent, PF
  156http://hl7.org/fhir/sid/cvxRho(D)-IG
  157http://hl7.org/fhir/sid/cvxRho(D) -IG IM
  158http://hl7.org/fhir/sid/cvxInfluenza, split virus, quadrivalent, preservative
  159http://hl7.org/fhir/sid/cvxRho(D) - Unspecified formulation
  160http://hl7.org/fhir/sid/cvxInfluenza A monovalent (H5N1), ADJUVANTED-2013
  801http://hl7.org/fhir/sid/cvxAS03 Adjuvant
  161http://hl7.org/fhir/sid/cvxInfluenza, injectable,quadrivalent, preservative free, pediatric
  162http://hl7.org/fhir/sid/cvxmeningococcal B, recombinant
  163http://hl7.org/fhir/sid/cvxmeningococcal B, OMV
  164http://hl7.org/fhir/sid/cvxmeningococcal B, unspecified
  165http://hl7.org/fhir/sid/cvxHPV9
  166http://hl7.org/fhir/sid/cvxinfluenza, intradermal, quadrivalent, preservative free
  167http://hl7.org/fhir/sid/cvxmeningococcal, unknown serogroups
  168http://hl7.org/fhir/sid/cvxInfluenza, adjuvanted, trivalent, PF
  169http://hl7.org/fhir/sid/cvxHep A, live attenuated
  170http://hl7.org/fhir/sid/cvxDTAP/IPV/HIB - non-US
  171http://hl7.org/fhir/sid/cvxInfluenza, MDCK, quadrivalent, PF
  172http://hl7.org/fhir/sid/cvxcholera, WC-rBS
  173http://hl7.org/fhir/sid/cvxcholera, BivWC
  174http://hl7.org/fhir/sid/cvxcholera, live attenuated
  175http://hl7.org/fhir/sid/cvxRabies - IM Diploid cell culture
  176http://hl7.org/fhir/sid/cvxRabies - IM fibroblast culture
  177http://hl7.org/fhir/sid/cvxPCV10
  178http://hl7.org/fhir/sid/cvxOPV bivalent
  179http://hl7.org/fhir/sid/cvxOPV ,monovalent, unspecified
  180http://hl7.org/fhir/sid/cvxtetanus immune globulin
  181http://hl7.org/fhir/sid/cvxanthrax immune globulin
  182http://hl7.org/fhir/sid/cvxOPV, Unspecified
  183http://hl7.org/fhir/sid/cvxYellow fever vaccine live - alt
  184http://hl7.org/fhir/sid/cvxYellow fever, unspecified
  185http://hl7.org/fhir/sid/cvxInfluenza, recombinant, quadrivalent, PF
  186http://hl7.org/fhir/sid/cvxInfluenza, MDCK, quadrivalent, preservative
  187http://hl7.org/fhir/sid/cvxzoster recombinant
  188http://hl7.org/fhir/sid/cvxzoster, unspecified formulation
  189http://hl7.org/fhir/sid/cvxHepB-CpG
  190http://hl7.org/fhir/sid/cvxTyphoid conjugate vaccine (TCV)
  191http://hl7.org/fhir/sid/cvxmeningococcal A polysaccharide (non-US)
  192http://hl7.org/fhir/sid/cvxmeningococcal AC polysaccharide (non-US)
  193http://hl7.org/fhir/sid/cvxHep A-Hep B, pediatric/adolescent
  194http://hl7.org/fhir/sid/cvxInfluenza, Southern Hemisphere
  195http://hl7.org/fhir/sid/cvxDT, IPV adsorbed
  196http://hl7.org/fhir/sid/cvxTd, adsorbed, preservative free, adult use, Lf unspecified
  197http://hl7.org/fhir/sid/cvxInfluenza, high-dose, quadrivalent, PF
  200http://hl7.org/fhir/sid/cvxinfluenza, Southern Hemisphere, pediatric, preservative free
  201http://hl7.org/fhir/sid/cvxInfluenza, Southern Hemisphere, quadrivalent, PF
  202http://hl7.org/fhir/sid/cvxinfluenza, Southern Hemisphere, quadrivalent, with preservative
  198http://hl7.org/fhir/sid/cvxDTP-hepB-Hib Pentavalent Non-US
  203http://hl7.org/fhir/sid/cvxmeningococcal conjugate quadrivalent, MenACWY-TT (MCV4)
  205http://hl7.org/fhir/sid/cvxInfluenza, adjuvanted, quadrivalent, PF
  206http://hl7.org/fhir/sid/cvxVaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection
  207http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
  208http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
  213http://hl7.org/fhir/sid/cvxSARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
  210http://hl7.org/fhir/sid/cvxCOVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL
  212http://hl7.org/fhir/sid/cvxCOVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL
  204http://hl7.org/fhir/sid/cvxEbola Zaire vaccine, live, recombinant, 1mL dose
  214http://hl7.org/fhir/sid/cvxEbola, unspecified
  211http://hl7.org/fhir/sid/cvxCOVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
  500http://hl7.org/fhir/sid/cvxCOVID-19 Non-US Vaccine, Product Unknown
  501http://hl7.org/fhir/sid/cvxCOVID-19 IV Non-US Vaccine (QAZCOVID-IN)
  502http://hl7.org/fhir/sid/cvxCOVID-19 IV Non-US Vaccine (COVAXIN)
  503http://hl7.org/fhir/sid/cvxCOVID-19 LAV Non-US Vaccine (COVIVAC)
  504http://hl7.org/fhir/sid/cvxCOVID-19 VVnr Non-US Vaccine (Sputnik Light)
  505http://hl7.org/fhir/sid/cvxCOVID-19 VVnr Non-US Vaccine (Sputnik V)
  506http://hl7.org/fhir/sid/cvxCOVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology
  507http://hl7.org/fhir/sid/cvxCOVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)
  508http://hl7.org/fhir/sid/cvxCOVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)
  509http://hl7.org/fhir/sid/cvxCOVID-19 PS Non-US Vaccine (EpiVacCorona)
  510http://hl7.org/fhir/sid/cvxCOVID-19 IV Non-US Vaccine (BIBP, Sinopharm)
  511http://hl7.org/fhir/sid/cvxCOVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)
  215http://hl7.org/fhir/sid/cvxPneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF
  216http://hl7.org/fhir/sid/cvxPneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF
  219http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose
  217http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose
  218http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose
  220http://hl7.org/fhir/sid/cvxHepB recombinant, 3-antigen, Al(OH)3
  221http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose
  222http://hl7.org/fhir/sid/cvxTick-borne encephalitis, unspecified
  223http://hl7.org/fhir/sid/cvxTick-borne encephalitis, inactivated, PF, 0.25mL
  224http://hl7.org/fhir/sid/cvxTick-borne encephalitis, inactivated, PF, 0.5mL
  225http://hl7.org/fhir/sid/cvxCOVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL
  226http://hl7.org/fhir/sid/cvxCOVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL
  512http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)
  513http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)
  514http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)
  515http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)
  516http://hl7.org/fhir/sid/cvxCOV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
  517http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)
  227http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose
  228http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose
  229http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose
  301http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose
  300http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose
  230http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL
  518http://hl7.org/fhir/sid/cvxCOVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
  519http://hl7.org/fhir/sid/cvxCOVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna
  520http://hl7.org/fhir/sid/cvxCOVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech
  521http://hl7.org/fhir/sid/cvxCOVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK
  231http://hl7.org/fhir/sid/cvxinfluenza, Southern Hemisphere, high-dose, quadrivalent
  303http://hl7.org/fhir/sid/cvxRSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF
  304http://hl7.org/fhir/sid/cvxRespiratory syncytial virus (RSV), unspecified
  305http://hl7.org/fhir/sid/cvxRSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF
  306http://hl7.org/fhir/sid/cvxRSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months
  307http://hl7.org/fhir/sid/cvxRSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months
  313http://hl7.org/fhir/sid/cvxCOVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL
  308http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL
  309http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL
  310http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL
  312http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL
  311http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL
  315http://hl7.org/fhir/sid/cvxRespiratory syncytial virus (RSV) MAB, unspecified
  314http://hl7.org/fhir/sid/cvxRespiratory syncytial virus (RSV) vaccine, unspecified
  316http://hl7.org/fhir/sid/cvxMeningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF
  317http://hl7.org/fhir/sid/cvxChikungunya live attenuated vaccine, 0.5 mL, PF
  318http://hl7.org/fhir/sid/cvxAnthrax, post-exposure prophylaxis
  319http://hl7.org/fhir/sid/cvxAnthrax vaccine, unspecified
  320http://hl7.org/fhir/sid/cvxInfluenza, MDCK, trivalent, preservative
  321http://hl7.org/fhir/sid/cvxInfluenza-avian, H5N8, monovalent, PF
  322http://hl7.org/fhir/sid/cvxInfluenza-avian, H5N8, monovalent, preservative
  324http://hl7.org/fhir/sid/cvxPoliovirus, inactivated, fractional-dose (fIPV)
  323http://hl7.org/fhir/sid/cvxInfluenza-avian, H5, unspecified formulation
  326http://hl7.org/fhir/sid/cvxRSV, mRNA, injectable, PF
  327http://hl7.org/fhir/sid/cvxPneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF
  328http://hl7.org/fhir/sid/cvxMeningococcal oligosaccharide (MenACWY), (MenB), PF
  329http://hl7.org/fhir/sid/cvxChikungunya, VLP, recombinant, 0.8 mL, PF
  330http://hl7.org/fhir/sid/cvxDengue fever, unspecified
  331http://hl7.org/fhir/sid/cvxInfluenza, Southern Hemisphere, trivalent, PF
  325http://hl7.org/fhir/sid/cvxVaccinia (smallpox, mpox), unspecified
  332http://hl7.org/fhir/sid/cvxRSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF
  333http://hl7.org/fhir/sid/cvxInfluenza, live, trivalent, intranasal, self/caregiver admin, PF
  302http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code